The PREVENT Trial: a Pragmatic Cluster Randomized Controlled Trial of a Multifaceted Fracture Prevention Model for Long-term Care
PREVENT
1 other identifier
interventional
3,060
1 country
1
Brief Summary
Hip fractures occur nearly twice as often for older adults residing in long-term care as they do in older adults of a similar age still living in other settings. Hip fractures are the leading cause of hospitalization and often result in loss of independence, problems with walking and sometimes death. To address this problem the PREVENT (Person-centered Routine Fracture PrEVENTion in LTC) program was designed for use in long-term care homes. PREVENT uses a tool ("fracture risk calculator") based on a residents electronic health record to capture who is most at risk of fracture due to osteoporosis and falls. The program then trains the health care team including doctors, pharmacists and nurses on the latest recommendations on how to best assist residents and their families in making treatment decisions. The healthcare teams are also given tools that help them stay on track such as templates for ordering medications, strategies to reduce falls and fractures and making care plans. The study will examine if this program is effective for decreasing hip fractures by assigning some homes to receive the PREVENT program (intervention group) and some homes to usual care (control group) and comparing the results.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 24, 2021
CompletedFirst Posted
Study publicly available on registry
July 1, 2021
CompletedStudy Start
First participant enrolled
June 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2027
ExpectedJuly 1, 2025
June 1, 2025
1.8 years
June 24, 2021
June 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of hip-fractures
Data extracted from the Discharge Abstract Database (DAD) and National Ambulatory Care Reporting System (NACRS). Scored as occurred: yes, no.
One year
Secondary Outcomes (10)
Number of non-hip fractures (wrist, spine, pelvis, humerus)
One year
Number of hospital transfers (emergency department and admissions)
One year
Number of deaths
One year
Change in number of falls
Baseline, 3, 6, 9 and 12 months
Change in level of pain
Baseline, 3, 6, 9 and 12 months
- +5 more secondary outcomes
Study Arms (2)
PREVENT Program
EXPERIMENTALPREVENT model
Control Group
NO INTERVENTIONResidents in homes allocated to the control group will receive usual care as provided within their home.
Interventions
A standardized PREVENT educational program will be offered to each intervention LTC home and health-care staff. The curricula includes video modules with fracture-prevention care recommendations and an orientation to the Fracture Prevention Toolkit. Using the Fracture Risk Scale (i.e., a clinical decision support tool embedded in the RAI-MDS 2.0), the LTC team will identify residents at high-risk for fracture and will implement the fracture prevention recommendations into care plans on an individual resident basis.
Eligibility Criteria
You may qualify if:
- Both profit and non-profit long-term care homes in Ontario, Canada.
- Homes must have a minimum of 50 occupied beds to participate; there is no maximum home size for participation.
- For both control and intervention homes, resident eligibility (and study cohorts) will be determined via the RAI-MDS 2.0 database.
You may not qualify if:
- Residents identified as having end-stage disease, who are comatose, receiving hospice or respite care and who have an expected short stay (90 days or less).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
McMaster University - St. Peter's Hospital
Hamilton, Ontario, L8M 1W9, Canada
Related Publications (1)
Papaioannou A, Feldman S, Katz P, Costa AP, Kennedy CC, Adachi JD, Boyd H, Giangregorio L, Heckman G, Hewston P, Hirdes J, Holroyd-Leduc J, Howard M, Ho J, Jaglal S, Kaasalainen S, Kristof L, Lau A, Lee J, McArthur C, Marr S, O'Donnell D, Rodrigues IB, Shankardass K, Siu H, Straus S, Thrall S, Tarride JE, Thabane L, Hafid S, Tung J, Hillier LM, Kane LL, Azizudin AM, Desinghe TD, Ioannidis G. Study protocol for a pragmatic, cluster, randomized controlled trial of a multifaceted fracture prevention model for long-term care: the PREVENT trial. Trials. 2026 Jan 9. doi: 10.1186/s13063-025-09398-1. Online ahead of print.
PMID: 41507969DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alexandra Papaioannou, MD, MSc
McMaster University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Executive Director, GERAS Centre for Aging Research, Hamilton Health Sciences
Study Record Dates
First Submitted
June 24, 2021
First Posted
July 1, 2021
Study Start
June 19, 2024
Primary Completion
March 31, 2026
Study Completion (Estimated)
March 31, 2027
Last Updated
July 1, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share